{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T22:02:43Z","timestamp":1788904963963,"version":"build-2803163510"},"reference-count":17,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Ocular Immunology and Inflammation"],"published-print":{"date-parts":[[2025,11,26]]},"DOI":"10.1080\/09273948.2024.2391985","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T11:26:16Z","timestamp":1724930776000},"page":"2245-2249","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":3,"title":["Intravenous Golimumab in the Treatment of Juvenile Idiopathic Arthritis and Its Associated Uveitis"],"prefix":"10.1080","volume":"33","author":[{"given":"Shawn","family":"Khan","sequence":"first","affiliation":[{"name":"University of Florida","place":["Gainesville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khushi","family":"Saigal","sequence":"additional","affiliation":[{"name":"University of Florida","place":["Gainesville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohum","family":"Sheth","sequence":"additional","affiliation":[{"name":"University of Florida","place":["Gainesville, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5533-9798","authenticated-orcid":false,"given":"Arash","family":"Maleki","sequence":"additional","affiliation":[{"name":"University of Florida","place":["Gainesville, USA"]},{"name":"The Ocular Immunology and Uveitis Foundation","place":["Waltham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2024,8,29]]},"reference":[{"issue":"2","key":"e_1_3_6_2_1","first-page":"390","article-title":"International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001","volume":"31","author":"Petty RE","year":"2004","unstructured":"Petty RE, Southwood TR, Manners P, Baum J, Glass DN, Goldenberg J, et al; International League of Associations for Rheumatology. International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390\u2013392.","journal-title":"J Rheumatol"},{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2018.01.002"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-017-0195-8"},{"issue":"5","key":"e_1_3_6_5_1","first-page":"1146","article-title":"Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey","volume":"34","author":"Foeldvari I","year":"2007","unstructured":"Foeldvari I, Nielsen S, K\u00fcmmerle-Deschner J, Espada G, Horneff G, Bica B, et al. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol. 2007;34(5):1146\u20131150.","journal-title":"J Rheumatol"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.09.048"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1614160"},{"issue":"4","key":"e_1_3_6_8_1","first-page":"652","article-title":"Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review","volume":"36","author":"Palmou-Fontana N","year":"2018","unstructured":"Palmou-Fontana N, Calvo-R\u00edo V, Mart\u00edn-Varillas JL, Fern\u00e1ndez-D\u00edaz C, Mesquida M, Ad\u00e1n A, et al. Golimumab in refractory uveitis associated to juvenile idiopathic arthritis: multicentre study of 7 cases and literature review. Clin Exp Rheumatol. 2018;36(4):652\u2013657.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2005.03.057"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.4161\/mabs.12304"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001262"},{"key":"e_1_3_6_12_1","volume-title":"2014 ACR\/ARHP Annual Meeting; 2014 Nov 14\u201319","author":"Westhovens R","unstructured":"Westhovens R, Keystone EC, Bingham CO III, Hsia EC, Kim L, et al. Long term safety of intravenous golimumab and comparison with subcutaneous golimumab in rheumatoid arthritis: results through 2 years [abstract number 479]. In: 2014 ACR\/ARHP Annual Meeting; 2014 Nov 14\u201319. Boston, MA: Arthritis Rheumatol. 2014;66(Suppl 10). https:\/\/acrabstracts.org\/abstract\/long-term-safety-of-intravenous-golimumab-and-comparison-with-subcutaneous-golimumab-in-rheumatoid-arthritis-results-through-2-years\/."},{"key":"e_1_3_6_13_1","unstructured":"Food and Drug Administration. SIMPONI ARIA\u00ae (golimumab) injection for intravenous use initial U.S. Approval: 2009. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/125433s032lbl.pdf. Published 2020. Accessed July 14 2024."},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12348-012-0081-y"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12969-021-00630-1"},{"key":"e_1_3_6_16_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2013.844265"},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajoc.2021.101014"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2020.1869787"}],"container-title":["Ocular Immunology and Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09273948.2024.2391985","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T17:10:12Z","timestamp":1765386612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/09273948.2024.2391985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,29]]},"references-count":17,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,11,26]]}},"alternative-id":["10.1080\/09273948.2024.2391985"],"URL":"https:\/\/doi.org\/10.1080\/09273948.2024.2391985","relation":{},"ISSN":["0927-3948","1744-5078"],"issn-type":[{"value":"0927-3948","type":"print"},{"value":"1744-5078","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,29]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ioii20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ioii20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2024-07-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-06","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-08-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}